Literature DB >> 2574777

Use of cyclosporin in psoriasis.

J D Bos1, M M Meinardi, T van Joost, F Heule, A V Powles, L Fry.   

Abstract

In the treatment of severe psoriasis, cyclosporin may achieve improvement or remission at low doses, but relapse usually occurs on withdrawal of treatment. An initial dose of 3 mg/kg per day is recommended. Complete remission should not be the objective, and the role of long-term maintenance cyclosporin therapy is uncertain because of potential side-effects--especially nephrotoxicity, hypertension, and a predisposition to malignancy. Guidelines are proposed for the assessment of such treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574777     DOI: 10.1016/s0140-6736(89)92941-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

Review 1.  Dermatology.

Authors:  M H Rustin
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

Review 2.  Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?

Authors:  B Lindelöf
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy.

Authors:  V P Vallat; P Gilleaudeau; L Battat; J Wolfe; R Nabeya; N Heftler; E Hodak; A B Gottlieb; J G Krueger
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

Review 5.  The Brain-Skin Connection and the Pathogenesis of Psoriasis: A Review with a Focus on the Serotonergic System.

Authors:  Ana M Martins; Andreia Ascenso; Helena M Ribeiro; Joana Marto
Journal:  Cells       Date:  2020-03-26       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.